Search Results - "Fox, C P"

Refine Results
  1. 1
  2. 2

    Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group by Vitali, C, Bombardieri, S, Jonsson, R, Moutsopoulos, H M, Alexander, E L, Carsons, S E, Daniels, T E, Fox, P C, Fox, R I, Kassan, S S, Pillemer, S R, Talal, N, Weisman, M H

    Published in Annals of the rheumatic diseases (01-06-2002)
    “…Classification criteria for Sjögren's syndrome (SS) were developed and validated between 1989 and 1996 by the European Study Group on Classification Criteria…”
    Get full text
    Journal Article
  3. 3

    Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Adults Characterized by High Viral Genome Load within Circulating Natural Killer Cells by Fox, C. P., Shannon-Lowe, C., Gothard, P., Kishore, B., Neilson, J., O'Connor, N., Rowe, M.

    Published in Clinical infectious diseases (01-07-2010)
    “…Epstein-Barr virus (EBV)-associated hemophagocytic lymphohistiocytosis (HLH) is a rare and aggressive disease usually encountered in the context of primary EBV…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Aspirin Use and Post-operative Bleeding from Dental Extractions by Brennan, M.T., Valerin, M.A., Noll, J.L., Napeñas, J.J., Kent, M.L., Fox, P.C., Sasser, H.C., Lockhart, P.B.

    Published in Journal of dental research (01-08-2008)
    “…Aspirin is a common, chronically administered preventive treatment for cardiovascular disease, but is often discontinued prior to invasive dental procedures…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Reduction in MRSA environmental contamination with a portable HEPA-filtration unit by Boswell, T.C., Fox, P.C.

    Published in The Journal of hospital infection (01-05-2006)
    “…There is renewed interest in the hospital environment as a potentially important factor for cross-infection with methicillin-resistant Staphylococcus aureus…”
    Get full text
    Journal Article
  10. 10

    Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England by Hounsome, L., Eyre, T. A., Ireland, R., Hodson, A., Walewska, R., Ardeshna, K., Chaganti, S., McKay, P., Davies, A., Fox, C. P., Kalakonda, N., Fields, P. A.

    Published in British journal of cancer (01-01-2022)
    “…Background We wished to examine treatment and outcome patterns in older diffuse large B-cell lymphoma (DLBCL) patients, with a focus on the effect of…”
    Get full text
    Journal Article
  11. 11

    Richter's transformation: Transforming the clinical landscape by Barrett, A., Appleby, N., Dreau, H., Fox, C.P., Munir, T., Eyre, T.A.

    Published in Blood reviews (01-03-2024)
    “…Richter transformation (RT) represents an aggressive histological transformation from chronic lymphocytic leukaemia, most often to a large B cell lymphoma. It…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Clinical course of primary Sjögren's syndrome: salivary, oral, and serologic aspects by Gannot, G, Lancaster, H E, Fox, P C

    Published in Journal of rheumatology (01-08-2000)
    “…To assess changes in symptoms and signs, salivary function, serologic activity, and disease progression in primary Sjogren's syndrome (SS). Treatment records…”
    Get more information
    Journal Article
  14. 14
  15. 15

    IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma by Fox, C. P., McMillan, A. K., Bishton, M. J., Haynes, A. P., Russell, N. H.

    Published in British journal of haematology (01-04-2008)
    “…Summary Two commonly used chemotherapy regimens for lymphoma salvage therapy were compared: ICE (ifosphamide, carboplatin and etoposide) ± rituximab and IVE…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation by LOCKHART, P. B, BRENNAN, M. T, KENT, M. L, PACKMAN, C. H, NORTON, H. J, FOX, P. C, FRENETTE, G

    Published in Bone marrow transplantation (Basingstoke) (01-04-2005)
    “…Pilocarpine hydrochloride has been reported to increase salivation and decrease oral mucositis in patients receiving head and neck radiotherapy, but there is…”
    Get full text
    Journal Article
  18. 18

    Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT by Burns, D M, Rana, S, Martin, E, Nagra, S, Ward, J, Osman, H, Bell, A I, Moss, P, Russell, N H, Craddock, C F, Fox, C P, Chaganti, S

    Published in Bone marrow transplantation (Basingstoke) (01-06-2016)
    “…EBV-associated post-transplant lymphoproliferative disease (PTLD) remains an important complication of allogeneic haematopoietic stem cell transplantation…”
    Get full text
    Journal Article
  19. 19
  20. 20

    The oral mucosa as a therapeutic target for xerostomia by Thelin, WR, Brennan, MT, Lockhart, PB, Singh, ML, Fox, PC, Papas, AS, Boucher, RC

    Published in Oral diseases (01-11-2008)
    “…Autoimmune disorders, medical interventions, and aging are all known to be associated with salivary gland hypofunction, which results in the uncomfortable…”
    Get full text
    Journal Article